Table 3 Multivariate analysis
Variables | Odds ratio | 95% Confidence interval | p-value | Adjusted odds ratio | 95% Confidence interval | p-value |
|---|---|---|---|---|---|---|
Age group (years) | ||||||
20–40 | 1.00 | |||||
40–60 | 1.51 | (0.78, 2.94) | 0.222 | |||
≥ 60 | 2.99 | (1.56, 5.73) | 0.001 | |||
Gender | ||||||
Male | 1.54 | (0.99, 2.40) | 0.062 | |||
Female | 1.00 | |||||
Co-morbidities | ||||||
Hypertension (Yes/No) | 0.71 | (0.45, 1.13) | 0.146 | |||
Diabetes (Yes/No) | 1.93 | (1.36, 2.75) | 0.000 | 1.55 | (1 01, 2.39) | 0.05 |
Lung disease (Yes/No) | 1.85 | (0.96, 3.56) | 0.063 | |||
Cardiac (Yes/No) | 2.57 | (1.52, 4.33) | 0.000 | 3.76 | (1.95, 7.25) | < 0.001 |
Type of oxygen support | ||||||
SLFO | 1.00 | |||||
HFO | 2.74 | (1.55, 4.83) | 0.000 | 2.35 | (1.26, 4.32) | 0.007 |
NIV | 10.37 | (6.29, 17.10) | 0.000 | 11.04 | (6.4, 18.9) | < 0.001 |
MV | 36.25 | (20.14, 65.23) | 0.000 | 40.51 | (21.010, 77.7) | < 0.001 |
Remdesivir treatment duration | ||||||
< 5 days | 1 | |||||
5 days | 0.28 | (0.19, 0.41) | < 0.001 | 0.29 | (0.19, 0.45) | < 0.001 |
≥ 6 days | 0.39 | (0.21, 0.72) | 0.002 | 0.40 | (0.20, 0.80) | 0.009 |
Concomitant medications | ||||||
Steroids | 1 | |||||
Others | 1.08 | (0.69, 1.69) | 0.735 | |||